Yutaka Hanazono

3.8k citations

113 papers · 3.1k indexed · h-index 30

Molecular Biology top 5%
Genetics top 2%
Oncology top 5%
Immunology top 5%
Genetics top 2%

Co-authors: Keiya Ozawa Cynthia E. Dunbar Hiroaki Mizukami Hisamaru Hirai Akihiro Kume Takashi Okada Shin‐ichi Muramatsu Stephanie Sellers
Topics: Virus-based gene therapy research (46 papers)CRISPR and Genetic Engineering (31 papers)Pluripotent Stem Cells Research (26 papers)
Cited by: Genetics Hematology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Neuroscience
Partner nations: Japan United States France

In The Last Decade

Yutaka Hanazono

107 papers receiving 3.0k citations

Peers

Countries citing papers authored by Yutaka Hanazono

Since Specialization

Citations

This map shows the geographic impact of Yutaka Hanazono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Hanazono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Hanazono more than expected).

Fields of papers citing papers by Yutaka Hanazono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Hanazono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Hanazono. The network helps show where Yutaka Hanazono may publish in the future.

Co-authorship network of co-authors of Yutaka Hanazono

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Hanazono. A scholar is included among the top collaborators of Yutaka Hanazono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Hanazono. Yutaka Hanazono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nonviral Ex Vivo Genome Editing in Mouse Bona Fide Hematopoietic Stem Cells with CRISPR/Cas9 2023 ·Methods in molecular biology ·Hiromasa Hara,(unknown),(unknown),Yutaka Hanazono	0
2	PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells 2023 ·SHILAP Revista de lepidopterología ·(unknown),Yuji Kashiwakura,Morisada Hayakawa,(unknown),Nobuhiko Kamoshita,(unknown),Hiroshi Inaba,Hiroshi Nishimasu,Hideki Uosaki,Yutaka Hanazono,Osamu Nureki,Tsukasa Ohmori	14
3	Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9 2021 ·Molecular Therapy — Methods & Clinical Development ·(unknown),Hideki Uosaki,Tsukasa Ohmori,Hiromasa Hara,Hitoshi Endo,Osamu Nureki,Yutaka Hanazono	8
4	Maternal administration of busulfan before in utero transplantation of human hematopoietic stem cells enhances engraftments in sheep 2012 ·Experimental Hematology ·Tomoyuki Abe,Shigeo Masuda,Yujiro Tanaka,(unknown),Yoshihiro Kitano,Satoshi Hayashi,Yutaka Hanazono,Yoshikazu Nagao	14
5	Generation of Naive-Like Porcine-Induced Pluripotent Stem Cells Capable of Contributing to Embryonic and Fetal Development 2012 ·Stem Cells and Development ·(unknown),Kazuaki Nakano,Yoshihisa Mizukami,Takuya Azami,Yoshikazu Arai,Hitomi Matsunari,(unknown),Takashi Nishimura,Masahito Watanabe,Tomoyuki Abe,Yutaka Furukawa,Kazuhiro Umeyama,Shinya Yamanaka,Masatsugu Ema,Hiroshi Nagashima,Yutaka Hanazono	106
6	Improved Efficacy and Safety of In Utero Cell Transplantation in Sheep Using an Ultrasound-Guided Method 2009 ·Cloning and Stem Cells ·Yoshikazu Nagao,Tomoyuki Abe,Hideaki Hasegawa,Yujiro Tanaka,Kyoko Sasaki,Yoshihiro Kitano,Satoshi Hayashi,Yutaka Hanazono	12
7	Dual antitumor mechanisms of Notch signaling inhibitor in a T‐cell acute lymphoblastic leukemia xenograft model 2009 ·Cancer Science ·Shigeo Masuda,Keiki Kumano,Takahiro Suzuki,Taisuke Tomita,Takeshi Iwatsubo,Hideaki Natsugari,Arinobu Tojo,Makoto Shibutani,Kunitoshi Mitsumori,Yutaka Hanazono,Seishi Ogawa,Mineo Kurokawa,Shigeru Chiba	22
8	Knockout Serum Replacement (KSR) Has a Suppressive Effect on Sendai Virus-Mediated Transduction of Cynomolgus ES Cells 2008 ·Cloning and Stem Cells ·Yukiko Kishi,Makoto Inoue,Yujiro Tanaka,Hiroaki Shibata,Shigeo Masuda,Tamako Ikeda,Mamoru Hasegawa,Yutaka Hanazono	2
9	Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene 2004 ·Gene Therapy ·Takahito Hara,Akihiro Kume,Yutaka Hanazono,Hiroaki Mizukami,Takashi Okada,Hisashi Tsurumi,Hisataka Moriwaki,Yasuji Ueda,M Hasegawa,K Ozawa	2
10	High-Level in Vivo Gene Marking after Gene-Modified Autologous Hematopoietic Stem Cell Transplantation without Marrow Conditioning in Nonhuman Primates 2004 ·Molecular Therapy ·(unknown),Yutaka Hanazono,Hiroaki Shibata,Naohide Ageyama,Yasuji Ueda,(unknown),Toshiaki Tabata,Takeyuki Nagashima,Masaaki Takatoku,(unknown),Susumu Ikehara,Masafumi Taniwaki,Keiji Terao,Mamoru Hasegawa,Keiya Ozawa	10
11	Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing Arginine–Vasopressin in brattleboro rats 2003 ·Molecular Therapy ·(unknown),Hiroaki Mizukami,Kazufumi Honda,Takashi Okada,Yutaka Hanazono,Akihiro Kume,Toshikazu Saito,Shun Ishibashi,Keiya Ozawa	22
12	Reduction of CTLL‐2 cytotoxicity by induction of apoptosis with a Fas‐estrogen receptor chimera 2003 ·Cancer Science ·(unknown),Akihiro Kume,Takashi Okada,Hiroaki Mizukami,Yutaka Hanazono,Keiya Ozawa	3
13	Collection and analysis of hematopoietic progenitor cells from cynomolgus macaques (Macaca fascicularis): Assessment of cross‐reacting monoclonal antibodies 2003 ·American Journal of Primatology ·Hiroaki Shibata,Yutaka Hanazono,Naohide Ageyama,Takeyuki Nagashima,Yasuji Ueda,Mamoru Hasegawa,Keiya Ozawa,Yasuhiro Yoshikawa,Keiji Terao	14
14	Genetic Manipulation of Primate Embryonic and Hematopoietic Stem Cells with Simian Lentivirus Vectors 2003 ·Trends in Cardiovascular Medicine ·Yutaka Hanazono,Takayuki Asano,Yasuji Ueda,Keiya Ozawa	9
15	New selective amplifier genes containing c-Mpl for hematopoietic cell expansion 2003 ·Biochemical and Biophysical Research Communications ·Takeyuki Nagashima,Yasuji Ueda,Yutaka Hanazono,Akihiro Kume,Hiroaki Shibata,Naohide Ageyama,Keiji Terao,Keiya Ozawa,Mamoru Hasegawa	5
16	Highly Efficient Gene Transfer into Primate Embryonic Stem Cells with a Simian Lentivirus Vector 2002 ·Molecular Therapy ·Takayuki Asano,Yutaka Hanazono,Yasuji Ueda,Shin‐ichi Muramatsu,Akihiro Kume,Hirofumi Suemori,Yutaka Suzuki,Yasushi Kondo,Kiyonori Harii,Mamoru Hasegawa,Norio Nakatsuji,Keiya Ozawa	34
17	Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport 2002 ·Neuroscience Research ·Yanyan Lu,Lijun Wang,Shin‐ichi Muramatsu,Kunihiko Ikeguchi,Ken’ichi Fujimoto,Takashi Okada,Hiroaki Mizukami,Takashi Matsushita,Yutaka Hanazono,Akihiro Kume,Toshiharu Nagatsu,Keiya Ozawa,Imaharu Nakano	53
18	Primary T Lymphocytes as Targets for Gene Therapy 2000 ·Journal of Hematotherapy & Stem Cell Research ·Yutaka Hanazono,Kevin Brown,Cynthia E. Dunbar	13
19	Green Fluorescent Protein Retroviral Vectors: Low Titer and High Recombination Frequency Suggest a Selective Disadvantage 1997 ·Human Gene Therapy ·Yutaka Hanazono,(unknown),Cynthia E. Dunbar,Robert Emmons	85
20	Distribution of Human Granulocyte Colony‐stimulating Factor Receptors on Hematopoietic and Nonhematopoietic Tumor Cell Lines 1990 ·Japanese Journal of Cancer Research ·Tomoaki Kuwaki,Takayuki Hosoi,Yutaka Hanazono,Haruhiko Tsumura,Fuyuki Ishikawa,(unknown),Kiyoshi Miyagawa,Fumimaro Takaku	14

About Yutaka Hanazono

Yutaka Hanazono is a scholar working on Genetics, Hematology and Microbiology, having authored 113 papers that have together received 3.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (46 papers), CRISPR and Genetic Engineering (31 papers) and Pluripotent Stem Cells Research (26 papers). The work is most often cited by research in Genetics (493 citations), Genetics (1.0k citations) and Hematology (395 citations). Yutaka Hanazono has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Keiya Ozawa, Cynthia E. Dunbar, Hiroaki Mizukami, Hisamaru Hirai, Akihiro Kume, Takashi Okada, Shin‐ichi Muramatsu, Stephanie Sellers, Ko Sasaki and Robert E. Donahue. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact